Phase I, randomized, double-masked, vehicle-controlled study to evaluate safety, tolerability and pharmacokinetics of recombinant human nerve growth factor eye drops in healthy volunteers

Phase I, randomized, double-masked, vehicle-controlled study to evaluate safety, tolerability and pharmacokinetics of recombinant human nerve growth factor eye drops in healthy volunteers

31/05/2013

Authors: Buggage R. et al.

Published in:

Investigative Ophthalmology and Visual Science

Ophthalmology